Assessing infrastructure readiness before procurement is what allows validated AI performance to translate to real-world performance.
THRIVE™ Infrastructure assessment maps your data architecture, system integration capability, cybersecurity posture, and scalability — identifying the invisible constraints that will determine whether AI actually works in your environment.
Core capabilities
Compute & Hardware Capacity
MOVEDHardware, processing, and network capability sufficient to support AI deployment under routine clinical conditions including peak load.
Interoperability
MOVEDCompatibility with existing EHR, TPS, OIS, and PACS infrastructure through standard APIs, HL7 FHIR, and DICOM compliance.
Deployment Data Pipeline
MOVEDReliability of data ingestion, preprocessing, format standardisation, and transfer processes that feed live AI systems.
Security & Access Control
MOVEDAuthentication protocols, audit logging, role-based access control, and PHI protection at the infrastructure layer.
Scalability
MOVEDAbility to expand AI deployment beyond pilot without degrading performance or increasing patient safety risk.
Onboarding Infrastructure
MOVEDTechnical capability to train, credential, and onboard staff to AI-enabled workflows — credentialing systems, sandbox environments, training platforms.
Data Governance
MOVEDPolicies, ownership structures, and stewardship processes ensuring data is managed, protected, and accessible for AI use.
How Infrastructure connects
Infrastructure determines whether technically validated AI performance translates to real-world performance. A model’s accuracy means nothing if your data pipeline corrupts its inputs.
Monitoring capability (E) depends entirely on infrastructure — you can’t detect drift if you can’t log predictions, and you can’t log predictions without pipeline instrumentation.
Security and access control (I) is the physical enforcement layer for privacy compliance (R). Policy without infrastructure is aspiration.
What the literature says
“Deployed models have the capability to be monitored in ‘real world’ use with a focus on maintained or improved safety and performance.”
— FDA, Good Machine Learning Practice (2021)
“Integration of AI systems in clinical settings is currently hampered by lack of trustworthiness and transparency, limited generalizability, fragility in real-world scenarios, inadequate interoperability with other clinical systems, potential bias in patient populations as well as legal and ethical questions.”
— IAEA PC9134 (2025)
“Risks of artificial intelligence technologies to safety and cybersecurity.”
— WHO, Ethics & Governance of AI for Health (2021)